News

Eli Lilly has rolled out a prefilled pen version of its weight-loss drug Mounjaro at the same price as vials, aiming to ...
Eli Lilly has launched its Mounjaro KwikPen in India at ₹14,000 for the 2.5 mg dose; the once-weekly injector targets ...
Enthusiasm for its weight loss medications is intensifying, and several companies are preparing oral formulations.
SINGAPORE] Locally headquartered biotech firm KPB Biosciences has failed to set aside a court order for its assets to be ...
The Singapore International Commercial Court (SICC) has upheld a worldwide freeze on USD 730 million in assets owned by ...
BNP Paribas Exane upgraded Novo Nordisk (NVO) to Neutral from Underperform with a $54 price target The firm sees a more balanced risk/reward, ...
Eli Lilly on Wednesday launched the easy-to-use injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees ...
Eli Lilly launched the pre-filled injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees (nearly $160) ...
Novo Nordisk has plummeted back to Earth after a stunning rise driven by Ozempic and Wegovy. Can the storied Danish pharma ...
CNBC's Silvia Amaro takes a look at the rise and fall in Novo Nordisk shares.
Lilly said in June it received approval from India’s drug regulator for its once-weekly Mounjaro Kwikpen, two days after Novo ...
KBP Biosciences Pte. Ltd. (the "Company") today issued a statement addressing a further decision by the Singapore ...